Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis

181Citations
Citations of this article
83Readers
Mendeley users who have this article in their library.

Abstract

Background and Purpose-Systemic inflammatory markers have been shown to predict future cardiovascular events, but whether they are associated with early atherosclerosis is uncertain. We investigated the relationship of inflammatory markers interleukin-6 (IL-6), high-sensitive C-reactive protein (hs-CRP), fibrinogen, monocyte count, and white cell count (WCC) with subclinical carotid atherosclerosis in a healthy community population. Methods-B-mode carotid ultrasound was performed on 1111 randomly selected male and female subjects aged 27 to 77 years. Serum IL-6, hs-CRP, plasma fibrinogen, monocyte count, and WCC were measured on all subjects, along with conventional cardiovascular risk factors. Results-Multivariate analysis showed that IL-6 (P<0.0001), fibrinogen (P=0.007), and monocyte count (P=0.001) were associated with carotid plaque formation in the whole population. Monocyte count remained associated independently with carotid plaque formation when adjusted further for conventional risk factors (odds ratio per SD increase in monocyte count 1.4; 95% CI, 1.13 to 1.73; P=0.002). IL-6 (P<0.0001), fibrinogen (P<0.0001), and monocyte count (P=0.04) were also associated with carotid intima-medial thickness (IMT) in the whole population. However, when adjusted further for conventional risk factors, none remained independently predictive of carotid IMT. Further analysis showed an age-monocyte interaction (P=0.03), with monocyte count being an independent predictor of carotid IMT in the older age group only (>53 years; P=0.003). Conclusion-In a healthy community population, monocyte count is a better independent predictor of common carotid IMT and plaque formation than IL-6, hs-CRP, fibrinogen, and WCC. Monocyte count may represent an inexpensive, easy-to-measure risk marker for subclinical carotid atherosclerosis.

References Powered by Scopus

Atherosclerosis - An inflammatory disease

20144Citations
N/AReaders
Get full text

Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association

5602Citations
N/AReaders
Get full text

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

5292Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Monocyte and macrophage differentiation: Circulation inflammatory monocyte as biomarker for inflammatory diseases

782Citations
N/AReaders
Get full text

ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice

425Citations
N/AReaders
Get full text

Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention

349Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Chapman, C. M. L., Beilby, J. P., McQuillan, B. M., Thompson, P. L., & Hung, J. (2004). Monocyte count, but not C-reactive protein or interleukin-6, is an independent risk marker for subclinical carotid atherosclerosis. Stroke, 35(7), 1619–1624. https://doi.org/10.1161/01.STR.0000130857.19423.ad

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 33

61%

Researcher 12

22%

Professor / Associate Prof. 7

13%

Lecturer / Post doc 2

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 30

63%

Biochemistry, Genetics and Molecular Bi... 9

19%

Agricultural and Biological Sciences 5

10%

Psychology 4

8%

Save time finding and organizing research with Mendeley

Sign up for free